Epidemiological, clinical and immune factors that influence the persistence of antiphospholipid antibodies in leprosy
Sign Up to like & getrecommendations! Published in 2019 at "Advances in Rheumatology"
DOI: 10.1186/s42358-019-0094-4
Abstract: IntroductionAntiphospholipid antibodies (aPL) are described in individuals with leprosy without the clinical features of antiphospholipid antibody syndrome (APS), a condition involving thromboembolic phenomena. We have described the persistence of these antibodies for over 5 years… read more here.
Keywords: antibodies leprosy; epidemiological clinical; apl antibodies; clinical immune ... See more keywords